| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,653 |
3,853 |
$167K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,150 |
1,860 |
$126K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
74 |
46 |
$16K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
137 |
132 |
$8K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
117 |
108 |
$7K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
25 |
17 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
625 |
535 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
721 |
465 |
$5K |
| 92551 |
|
741 |
669 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
102 |
81 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
70 |
69 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
51 |
43 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
87 |
72 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
230 |
197 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
161 |
77 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
68 |
64 |
$1K |
| 99173 |
|
778 |
699 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
120 |
102 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
14 |
14 |
$782.76 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
35 |
30 |
$456.17 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
35 |
30 |
$421.08 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
29 |
24 |
$308.97 |
| 81002 |
|
169 |
117 |
$260.44 |
| 85018 |
|
16 |
12 |
$37.76 |
| 81025 |
|
14 |
12 |
$31.55 |
| 94761 |
|
250 |
121 |
$16.83 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
12 |
$8.04 |
| 90670 |
|
12 |
12 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
137 |
97 |
$0.00 |
| 96127 |
|
16 |
14 |
$0.00 |